{"date":"2025-02-27","count":16,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4735-2025-02-27-2024-dr1nei","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-02-27","time":"20:24:08","subject":"公告本公司現金增資董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-02-27 20:24，「公告本公司現金增資董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-02-27-2023-kau167","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-02-27","time":"20:23:38","subject":"公告本公司113年現金增資股款催繳事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-02-27 20:23，「公告本公司113年現金增資股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-02-27-1917-1lzzfh4","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-02-27","time":"19:17:51","subject":"公告本公司董事會決議以私募方式辦理現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-02-27 19:17，「公告本公司董事會決議以私募方式辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-02-27-1916-b9gsdb","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-02-27","time":"19:16:40","subject":"公告本公司員工認股權憑證轉換普通股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-02-27 19:16，「公告本公司員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-02-27-1915-cievxs","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-02-27","time":"19:15:35","subject":"本公司董事會決議召開114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-02-27 19:15，「本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-02-27-1914-h78woa","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-02-27","time":"19:14:41","subject":"公告本公司不繼續辦理113年股東常會通過之私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-02-27 19:14，「公告本公司不繼續辦理113年股東常會通過之私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-02-27-1913-bwopfv","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-02-27","time":"19:13:42","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-02-27 19:13，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-02-27-1910-1hku5w3","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-02-27","time":"19:10:15","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-02-27 19:10，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-02-27-1842-1fnar9b","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-02-27","time":"18:42:18","subject":"公告本公司董事會決議通過發行114年度第一次員工認股權憑證","clause":"第9款","fact_date":"2025-02-27","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-02-27 18:42，「公告本公司董事會決議通過發行114年度第一次員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2025-02-27-1819-1u3jkqc","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2025-02-27","time":"18:19:38","subject":"公告113年第四季財務報告董事會預計召開日期為114年3月7日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2025-02-27 18:19，「公告113年第四季財務報告董事會預計召開日期為114年3月7日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-02-27-1754-nt5gla","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-02-27","time":"17:54:04","subject":"公告董事會決議股利分派","clause":"第31款","fact_date":"2025-02-27","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-02-27 17:54，「公告董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-02-27-1753-tulf6t","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-02-27","time":"17:53:27","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"第32款","fact_date":"2025-02-27","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-02-27 17:53，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-02-27-1752-1hku5w3","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-02-27","time":"17:52:52","subject":"公告本公司董事會通過113年度合併財務報告","clause":"第43款","fact_date":"2025-02-27","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-02-27 17:52，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-02-27-1711-1riwyff","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-02-27","time":"17:11:44","subject":"公告本公司董事會決議召開一一四年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-02-27 17:11，「公告本公司董事會決議召開一一四年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-02-27-1708-bwopfv","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-02-27","time":"17:08:41","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-02-27 17:08，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-02-27-1652-1hku5w3","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-02-27","time":"16:52:34","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-02-27 16:52，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}